The first steps have been taken, but there is still a long way to go before #anle138b can be used against #Parkinson’s and other #neurodegenerative diseases. #MODAG GmbH is responsible for further development and clinical testing. Since 2021, they collaborate with @tevapharm.
0
0
1
0